Cargando…
Rational application of targeted therapeutics in mucinous colon/appendix cancers with positive predictive factors
Molecular‐targeted therapies have demonstrated disappointing results against most advanced solid cancers. This may largey be attributed to irrational drug use against unselected cancers. We investigated the efficacy of dual MEK‐PI3K drug therapy against KRAS mutated mucin 2 (MUC2)‐secreting LS174T c...
Autores principales: | Dilly, Ashokkumar, Honick, Brendon D., Lee, Yong J., Bartlett, David L., Choudry, Haroon A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050077/ https://www.ncbi.nlm.nih.gov/pubmed/31958897 http://dx.doi.org/10.1002/cam4.2847 |
Ejemplares similares
-
Synergistic apoptosis following endoplasmic reticulum stress aggravation in mucinous colon cancer
por: Dilly, Ashok K., et al.
Publicado: (2020) -
Targeting G-protein coupled receptor-related signaling pathway in a murine xenograft model of appendiceal pseudomyxoma peritonei
por: Dilly, Ashok K., et al.
Publicado: (2017) -
Mucinous adenocarcinona of the appendix
por: Crenitte, Milton Roberto Furst, et al.
Publicado: (2013) -
Mucinous adenocarcinoma of the appendix with inguinal node metastases
por: Vaz-Pereira, Ricardo, et al.
Publicado: (2021) -
Value of the log odds of positive lymph nodes for prognostic assessment of colon mucinous adenocarcinoma: Analysis and external validation
por: Cai, Huajun, et al.
Publicado: (2021)